{
    "root": "35ac52c3-31af-5bed-e063-6394a90ae378",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "escitalopram",
    "value": "20250521",
    "ingredients": [
        {
            "name": "BUTYLATED HYDROXYANISOLE",
            "code": "REK4960K2U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_76359"
        },
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "HYDROXYPROPYL CELLULOSE (1600000 WAMW)",
            "code": "RFW2ET671P",
            "drugbank_id": "https://go.drugbank.com/drugs/DB00840"
        },
        {
            "name": "HYPROMELLOSES",
            "code": "3NXW29V3WO",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "ESCITALOPRAM OXALATE",
            "code": "5U85DBW7LO",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_36791"
        }
    ],
    "indications": {
        "text": "escitalopram tablets selective serotonin reuptake inhibitor ( ssri ) indicated : acute maintenance treatment major depressive disorder ( mdd ) adults adolescents aged 12 17 years ( 1.1 ) acute treatment generalized anxiety disorder ( gad ) adults ( 1.2 )",
        "doid_entities": [
            {
                "text": "major depressive disorder (DOID:1470)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1470"
            },
            {
                "text": "depressive disorder (DOID:1596)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1596"
            },
            {
                "text": "generalized anxiety disorder (DOID:14320)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_14320"
            },
            {
                "text": "anxiety (DOID:2030)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_2030"
            }
        ],
        "orphanet_entities": [
            {
                "disease": "acute maintenance treatment",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_497130"
            }
        ]
    },
    "contraindications": {
        "text": "escitalopram tablets administered daily , morning evening , without food .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "escitalopram tablets , usp 10 mg available white , round , biconvex , film coated tablets , engraved `` 74 `` score one side plain side . supplied follows : ndc 60760-895-30 bottles 30 ndc 60760-895-90 bottles 90 storage handling store 20\u00bac 25\u00bac ( 68\u00baf 77\u00baf ) ; excursions permitted 15\u00bac 30\u00bac ( 59\u00baf 86\u00baf ) [ usp controlled room temperature ] . dispense tight container [ usp ] .",
    "adverseReactions": "serotonin syndrome maois : maois intended treat psychiatric disorders escitalopram tablets within 14 days stopping treatment escitalopram tablets . escitalopram tablets within 14 days stopping maoi intended treat psychiatric disorders . addition , start escitalopram tablets patient treated linezolid intravenous methylene blue ( 4.1 ) . pimozide : concomitantly ( 4.2 ) . known hypersensitivity escitalopram citalopram inactive ingredients ( 4.3 ) .",
    "indications_original": "Escitalopram tablets are a selective serotonin reuptake inhibitor (SSRI) indicated for: Acute and Maintenance Treatment of Major Depressive Disorder (MDD) in adults and adolescents aged 12 to 17 years ( 1.1 ) Acute Treatment of Generalized Anxiety Disorder (GAD) in adults ( 1.2 )",
    "contraindications_original": "Escitalopram tablets should be administered once daily, in the morning or evening, with or without food.",
    "warningsAndPrecautions_original": "Escitalopram Tablets, USP 10 mg are available as White, round, biconvex, film coated tablets, engraved \"74\" over score on one side and plain on the other side.\n                  They are supplied as follows:\n                  NDC 60760-895-30 BOTTLES OF 30\n                  \n                  NDC 60760-895-90 BOTTLES OF 90\n                  \n                  \n                  Storage and Handling\n                  Store at 20\u00baC to 25\u00baC (68\u00baF to 77\u00baF); excursions permitted from 15\u00baC to 30\u00baC (59\u00baF to 86\u00baF) [see USP Controlled Room Temperature]. Dispense in a tight container [see USP].",
    "adverseReactions_original": "Serotonin Syndrome and MAOIs: Do not use MAOIs intended to treat psychiatric disorders with escitalopram tablets or within 14 days of stopping treatment with escitalopram tablets. Do not use escitalopram tablets within 14 days of stopping an MAOI intended to treat psychiatric disorders. In addition, do not start escitalopram tablets in a patient who is being treated with linezolid or intravenous methylene blue ( 4.1 ). Pimozide: Do not use concomitantly ( 4.2 ). Known hypersensitivity to escitalopram or citalopram or any of the inactive ingredients ( 4.3 ).",
    "drug": [
        {
            "name": "escitalopram",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_36791"
        }
    ]
}